STK11 and cancer: While the inhibition of mTOR activity as well as activation by the tumor suppressor LKB1 serve as a basis for AMPK’s anti-tumor effects, induction of potentially pro-survival pathways like autophagy and glucose uptake have been proposed to challenge the molecule’s anti-cancer role [26].